CrestecBio.
脳と臓器を護る高分子医薬の開発
Japan · Founded 2021
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- crestecbio.com
About
CrestecBio is a Japanese drug discovery startup founded in December 2021 that develops neuroprotective polymer-based treatments for ischemic stroke and related brain diseases. Its lead candidate, CTB211, is a redox nanoparticle formulation originally developed at the University of Tsukuba that scavenges reactive oxygen species to protect neurons from cerebral ischemia-reperfusion injury following thrombectomy. The company raised a ¥150M ($1.7M) seed round and is targeting acute ischemic stroke, a condition affecting approximately 300,000 patients per year in Japan and 800,000 in the United States.
Summary
CrestecBio. is a Biotech company based in Japan, founded in 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/crestecbio"><img src="https://indexed.vc/api/badge/company/crestecbio" alt="CrestecBio. on Indexed.vc" width="260" height="76" /></a>